Introduction
Asthma is not an obstacle to athletic activities, and there are very successful competitive athletes who have asthma.' Swedish doctors who are consultants to the ski clubs have observed that airways symptoms and the use of antiasthmatic drugs, mainly 2 stimulants, are more common among cross country skiers than in nonskiers. This has recently been confirmed by a postal inquiry.2 Cross country skiing differs from most other sports, in that the athletic effort is conducted at low temperature. Training and competitions are often performed in temperatures below -15°C, implying ventilation with large amounts of cold air for several hours a week, for several months of the year. Inhaling cold air is a trigger for bronchoconstriction in asthmatic subjects.34 To our knowledge, however, there has been no report suggesting that breathing large amounts of cold air for long periods causes asthma in healthy subjects. To elucidate matters we undertook a study of asthma-like symptoms, lung function, and bronchial responsiveness in elite cross country skiers and referents. To see whether possible differences between the skiers and referents might be observed only during the ski season we conducted identical trials in the winter and in the summer.
Subjects and methods
All 47 elite skiers from six Swedish cross country ski clubs were invited to participate. Clubs were selected on two grounds: most of the members were elite skiers, and the clubs were located near the two centres (Stockholm and Ostersund) where the study was performed. Five of the 47 skiers did not attend, leaving 42 who participated (36 men, six women; mean age 24 (range 16-50)), most of who were national elite skiers. They had been active competitors for 13 (range [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] years, and the estimated mean training time in the year before the study was 406 (100-680) hours. Referents were 29 healthy hospital or laboratory workers and students (24 men, five women; mean age 28 (20- 7 In Stockholm the methacholine challenge tests were performed with a jet nebuliser (model MA2, Astra Meditec, Gothenburg, Sweden) with an output of 0-38 (±0013) ml/min. The method has been described. 
Discussion
This study shows that asthma, asthma-like symptoms, and bronchial hyperresponsiveness occur more frequently in cross country skiers than in healthy nonskiers. Moreover, in this series symptoms of asthma and bronchial hyperresponsiveness that were present in the winter-that is, at a time of strenuous training and competition in cold air-remained unchanged in the summer, when the skiers had not been exposed to cold air for several months.
Inhaling cold air induces bronchoconstriction and exacerbates the bronchoconstriction that occurs after exercise in patients with asthma.34 It has also been shown that inhaling cold air before a bronchial histamine provocation test transiently increases bronchial responsiveness in healthy9 and asthmatic subjects.'" In healthy subjects strenuous exercise in cold air induces a greater bronchoconstrictor response to histamine than exercise at room temperature." Thus data suggest that breathing cold air for a short period influences We recorded asthma (as defined by our criteria and diagnosed by physicians) in over half of the skiers. Physician diagnosed asthma was recorded in 13 skiers (31%). By comparison, the prevalance of physician diagnosed and self reported asthma in Sweden is 5_7%.12 13 The prevalence of asthma based on reports of symptoms and bronchial hyperreactivity has been estimated as 6 2 angonists in humans even if high doses were used. Inhalation of salbutamol did, however, increase high intensity power output on a bicycle ergometer,2' and oral salbutamol increased voluntary muscle strength in humans. 22 We cannot deny categorically that these effects might be relevant in short term intense anaerobic work but we think that they would be lost in skiing and other types of prolonged work.
In this study 15 of 42 skiers (36%) used antiasthmatic drugs regularly. Possible explanations for this high usage as compared with that in the study by Larsson et aP1 are twofold. Firstly, we included only elite skiers, who may have had a history of more intensive training than skiers selected on a general basis; secondly, the skiers studied by Larsson et aP were younger (mean age 18) than those in our series.
Of the 10 skiers who did not have asthma according to our criteria (normal bronchial responsiveness) but who were taking antiasthmatic agents, all had symptoms of asthma. Nine had physician diagnosed asthma and all 10 were receiving inhaled steroids. Possibly these skiers had asthma but also normal bronchial responsiveness owing to regular long term treatment with inhaled steroids.
On the other hand, if skiers believed that treatment with antiasthmatic drugs improved athletic performance they might overreport airways symptoms in order to excuse the drug. For the same reason there might be a risk of a falsely high prevalence of self reported and, possibly, physician diagnosed asthma in the group, although these questions seem to have high specificity in epidemiological studies.2'
As measurements of bronchial responsiveness have low specificity for asthma, it may be that we overestimated the prevalence of the condition in our series. Weighing against any such small possibility, however, is the strength of our data, which speak in favour of a very high asthma prevalence among skiers. We found no evidence of overuse 
Patients, methods, and results
The study was approved by the local hospital ethics committee. Patients in whom intra-articular steroid injections were indicated were asked if they wished to participate. After patients had given informed consent, synovitis in the index joint23 and at other sites was assessed.4 Local synovitis was graded according to an articular index developed for use at the knee. An "active," inflamed knee is defined by the presence of three or more of the following: stiffness lasting for more than 30 minutes in the early moming or after inactivity, synovial thickening, local warmth, tenderness, and moderate synovial effusion.23 Depot methylprednisolone was used for all injections and was mixed with a radiographic contrast medium, iopamicfol. The index joint was aspirated and injected, and the patient had a single plain radiograph of this joint. Patients were reviewed at six weeks by the same assessor; the Ritchie index and the assessment of synovitis were repeated blind to the results of the previous radiological clinical findings.24 Radiographs were read blind by one consultant radiologist (AM). Results were analysed by a X2 test.
Overall, 109 patients were studied; their median age was 68 (range 23-89). Forty four patients had rheumatoid arthritis, 52 osteoarthritis, and 13 
